Long-term prognosis following cerebrovascular events of different etiologies

ISRCTN ISRCTN57453322
DOI https://doi.org/10.1186/ISRCTN57453322
Secondary identifying numbers DI 327/9-1
Submission date
14/04/2006
Registration date
13/06/2006
Last edited
13/06/2006
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Dr Christian Weimar
Scientific

Hufelandstr. 55
Essen
45122
Germany

Phone +49 (0)201 723 2495
Email stroke.med@uni-essen.de

Study information

Study designProspective observational cohort study
Primary study designInterventional
Secondary study designCohort study
Study setting(s)Not specified
Study typeDiagnostic
Scientific title
Study objectivesTo determine the rate of recurrence in patients with cerebrovascular events of defined etiology
Ethics approval(s)Ethics Committee of the University of Essen reviewed the protocol of this trial and confirmed that ethical approval was not required.
Health condition(s) or problem(s) studiedCerebral stroke and TIA
InterventionPatients are followed-up via telephone interview to determine the long-term rate of recurrence in patients with predefined stroke etiologies
Intervention typeOther
Primary outcome measureRecurrent stroke
Secondary outcome measuresMortality of any cause
Overall study start date01/09/2002
Completion date31/12/2009

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants3000
Key inclusion criteriaPatients with acute cerebrovascular events of defined etiology including:
1. Cardiac right-to-left shunt
2. Transient ischemic attack (TIA) with symptoms lasting <1 hour
3. Intracerebral bleeding
4. Intracranial stenosis
5. Dissection of brain supplying arteries
6. Coagulation disorder
7. Previous history of migraine
8. Basilar artery occlusion
9. Vasculitis
10. Arteriovenous malformation
11. Moyamoya syndrome
Key exclusion criteriaInability or refusal to provide consent for study participation
Date of first enrolment01/09/2002
Date of final enrolment31/12/2009

Locations

Countries of recruitment

  • Germany

Study participating centre

Hufelandstr. 55
Essen
45122
Germany

Sponsor information

German Research Foundation (Deutsche Forschungsgemeinsschaft) (DFG)
Research organisation

Kennedeyallee 40
Bonn
53175
Germany

Email theodora.hogenkamp@dfg.de
Website http://www.dfg.de
ROR logo "ROR" https://ror.org/018mejw64

Funders

Funder type

Research organisation

German Research Foundation (Deutsche Forschungsgemeinsschaft) (DFG) DI 327/9-1

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan